Authorized Generics – the IDENTICAL option patients prefer
With generics representing more than 80%* of all prescriptions today, Brand Pharmaceutical companies absorb substantial loss of revenue as their brand products become replaced with generic market entrants. Prasco addressed this problem – and helped pave the way for brand lifecycle extension through its Authorized Generics program.
*Source: IMS Health, National Sales Perspectives, April 2012, National Prescription Audit, Dec. 2011, Branded generics disaggregrated.
Authorized Generics are an innovative solution – an opportunity to extend product lifecycles and provide partners, pharmacists and patients a preferable alternative to generics. Success in AGs requires a reliable and experienced partner to help navigate challenges and marketplace complexities to ensure ultimate success.
With a history of bringing more AGs to market than anyone in the industry, Prasco has earned a reputation as a highly qualified, most trusted source for lifecycle extension. Why? Because we invest in resources – human and material – that make our company smarter, faster and more imaginative. And because we understand the value of forming close-knit partnerships to solve complex challenges.
Authorized Generics for Brand Pharmaceutical Companies
Is your brand nearing the end of its patent exclusivity? Extend your brand’s life with the leaders in Authorized Generics.
Authorized Generics for Pharmacists
AGs are growing in both popularity and preference. See how they can benefit your pharmacy practice, and your patients.
Authorized Generics for Consumers
Identical to brand name drugs in every way – available at generic prices.
Authorized Generic Products
Explore our inventory of Authorized Generic products.